. Focal segmental sigmoid wall thickening with surrounding infl ammatory changes superimposed upon the background of sigmoid diverticulosis consistent with sigmoid diverticulitis.
and further molecular analysis. Follow-up at 4 years showed a normal psychomotor, social and intellectual development, scoliosis of the thoracic part of the backbone, and no facial or hand and feet dysmorphism.
Using the comparative genomic hybridization technique we revealed deletions of 7q11.1-7q11.2, 16p11.2-16p13.2, 16p13.3, 16q11.2-16q12.2 and 19p13. 1-19p13.3 chromosomal regions in the esophagus ( Figure 1 ) and no chromosomal aberrations in blood ( Figure 2 ) in the same patient resulting in somatic mosaicism. No other tissues were analyzed. We validated 19p13 deletion using quantitative real-time PCR and MLPA.
Recent scientifi c reports suggest that in the process of cell diff erentiation genome rearrangements may occur (5) (6) (7) . Th is somatic cell mosaicism can be formed aft er fertilization in the early stages of embryonic development, being one of the mechanisms for the diff erentiation of various tissues ( 8 ) . More and more reports in the literature describe somatic mosaicism as well as the cause of various diseases ( 9 ) . Th e chromosome deletions described by us in this paper are large DNA losses and may be pathogenic alterations with significance in the etiology of this developmental defect.
We suspect that 7q11. ( 10 ) .
We hypothesize that genetic mosaicism may be the cause of the EA and this readily explains the diffi culty in identifying pathogenic mutations in patients with isolated EA.
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Th e authors declare no confl ict of interest. To the Editor: Fecal microbiota transplantation (FMT) has become a cornerstone of the management of recurrent and refractory Clostridium diffi cile infection (CDI) ( 1 ) . Although it is safe and tolerable, adverse events have been reported with FMT via colonoscopy ( 1-5 ). Here we report the fi rst case of diverticulitis occurring aft er an FMT for the treatment of recurrent CDI.
Diverticulitis after Fecal
Th e patient was a 78-year-old Caucasian woman with a history of recurrent diverticulitis who had at least four episodes of recurrent CDI and had been treated with metronidazole and vancomcyin. She also had a history of coronary atherosclerotic heart disease, insulin-dependent diabetes, and hypertension. She had a partial colectomy over 10 years ago for self-reported Crohn's disease that had since been in remission. Because of the history of recurrent CDI, an FMT via colonoscopy was performed. One hundred grams of donor stool diluted in 250 ml of sterile saline, as previously described, was infused into the most proximal colon ( 6 ) . Th e colonoscopy revealed moderate diverticular disease in the left colon, and no macroscopic evidence of Crohn's disease. Th e FMT procedure was performed without diffi culty, and the patient was discharged from the endoscopy suite with no complaints. On her ride home 2 to 3 hours aft er the procedure, the patient developed severe diff use abdominal pain. She went to a local emergency department (ED) and was found to be febrile to 40°C. A CT scan performed at that ED visit confi rmed uncomplicated left -sided diverticulitis ( Figure 1 ). She was admitted to the hospital and placed on antibiotics, to which she responded well and was discharged home uneventfully. In the past 3 months post FMT, the patient has not had a recurrence of CDI despite being treated with antibiotics aft er the FMT.
Diverticulitis as a complication of FMT has never been reported in the literature. Th e pathogenesis of diverticulitis is not fully understood; however, the literature does highlight the role of dysbiosis as a plausible mechanism ( 7 ) . Fecal material may collect in a diverticulum, leading to obstruction followed by distention and fl ora overgrowth. Aerobic and anaero-Letters to the Editor nature publishing group bic microbes implicated in diverticulitis include Escherichia coli, Streptococcus spp., Bacteroides spp., Peptostreptococcus, Clostridium, and Fusobacterium ( 8 ). Our patient developed diverticulitis subsequent to FMT, which begs the question whether FMT can be an iatrogenic cause of dysbiosis through alterations of gut microbiome and subsequent infl ammation.
Dysbiosis is also associated with infl ammatory bowel disease (IBD). Case reports of worsening of IBD are reported aft er FMT, which may be related to attempts at realtering the gut microbiome ( 9 ) . In recurrent CDI, FMT disrupts and typically restores the gut microbiome with commensal organisms that prevent it. Studies have shown increases in Bacteroides , Lachnospiraceae , Peptostreptococcaceae , and Ruminococcaceae in post-FMT stool samples, and abundances of Streptococcus , Veillonella , and Enterococcus ; Klebsiella was signifi cantly reduced in post-FMT stool samples (10) (11) (12) . No diff erences in the relative abundance of a specifi c genus were seen when samples were compared by the time period of collection ( 12 ) . Th is suggests that changes to gut microbiome occur relatively quickly aft er FMT and may be permanent.
Th e above studies demonstrate a rise in the number of gut microbiome post FMT that could be involved in the pathogenesis of diverticulitis. FMT may be a source of diverticulitis by the induction of an infl ammatory response to the altered microbiome generated aft er FMT. Rare reports of diverticulitis aft er colonoscopy have also been reported; therefore, it may not be possible to determine cause and eff ect with regard to FMT and diverticulitis without additional reporting by others ( 13 ) . FMT is a safe method to treat recurrent and refractory CDI; however, complications are known to arise, and diverticulitis should be considered as a potential complication.
